Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net (loss)/income per share

The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2024 and 2023 (in thousands, except number of shares and per share amounts):

	Year Ended December 31,
Numerator:	December 31, 2024		December 31, 2023
Net loss	$	(61,183)	$	(73,447)
Net loss attributable to noncontrolling interest	109		100
Net loss attributable to Barinthus Biotherapeutics plc shareholders	$	(61,074)	$	(73,347)
Denominator:
Weighted-average ordinary shares outstanding, basic	39,348,240		38,386,491
Weighted-average ordinary shares outstanding, diluted	39,348,240		38,386,491
Net loss per share attributable to ordinary shareholders, basic	$	(1.55)	$	(1.91)
Net loss per share attributable to ordinary shareholders, diluted	$	(1.55)	$	(1.91)